Wu, K.-L.; Chang, C.-Y.; Sung, H.-Y.; Hu, T.-Y.; Kuo, L.-K.
Association of Tocilizumab and Invasive Aspergillosis in Critically Ill Patients with Severe COVID-19 Pneumonia and Acute Respiratory Distress Syndrome. J. Fungi 2022, 8, 339.
https://doi.org/10.3390/jof8040339
AMA Style
Wu K-L, Chang C-Y, Sung H-Y, Hu T-Y, Kuo L-K.
Association of Tocilizumab and Invasive Aspergillosis in Critically Ill Patients with Severe COVID-19 Pneumonia and Acute Respiratory Distress Syndrome. Journal of Fungi. 2022; 8(4):339.
https://doi.org/10.3390/jof8040339
Chicago/Turabian Style
Wu, Kuo-Lun, Chia-Yuan Chang, Heng-You Sung, Ting-Yu Hu, and Li-Kuo Kuo.
2022. "Association of Tocilizumab and Invasive Aspergillosis in Critically Ill Patients with Severe COVID-19 Pneumonia and Acute Respiratory Distress Syndrome" Journal of Fungi 8, no. 4: 339.
https://doi.org/10.3390/jof8040339
APA Style
Wu, K.-L., Chang, C.-Y., Sung, H.-Y., Hu, T.-Y., & Kuo, L.-K.
(2022). Association of Tocilizumab and Invasive Aspergillosis in Critically Ill Patients with Severe COVID-19 Pneumonia and Acute Respiratory Distress Syndrome. Journal of Fungi, 8(4), 339.
https://doi.org/10.3390/jof8040339